ADIL Live signaler | Maksimer profitt med Getagraph.com

Live Chart Being Loaded With Signals

Commentary (30 apr 2024 @ 22:00):

Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment or prevention of addiction and related disorders...

Stats
Dagens volum	236 415
Gjennomsnittsvolum	6.52M
Markedsverdi	6.89M
EPS	$-1.154 ( 2024-04-04 )
Neste inntjeningsdato	( $-0.510 ) 2024-05-10
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.350
ATR14	$0.0150 (0.88%)

Insider Trading

Date	Person	Action	Amount	type
2024-03-25	Gilliland Robertson H.	Buy	12 000	Stock Option (Right to Buy)
2024-03-25	Newman James W. Jr.	Buy	12 000	Stock Option (Right to Buy)
2024-03-25	Truluck Joseph	Buy	25 000	Stock Option (Right to Buy)
2024-03-25	Claiborne Cary J	Buy	60 000	Stock Option (Right to Buy)
2024-03-25	Anderson J. Kermit	Buy	12 000	Stock Option (Right to Buy)

INSIDER POWER
91.12
Last 98 transactions
Buy: 7 510 922 \| Sell: 1 943 977

Volum Korrelasjon

Lang: -0.10 (neutral)

Kort: -0.74 (moderate negative)

Signal:(46.192) Neutral

Adial Pharmaceuticals Inc Korrelasjon

10 Mest positive korrelasjoner
EXFY	0.967
ELEV	0.966
DRVN	0.965
GSIT	0.964
TSVT	0.963
CMBM	0.958
FGEN	0.956
IPGP	0.956
CMCT	0.952
NNOX	0.951

10 Mest negative korrelasjoner
NVAC	-0.958
PRDO	-0.955
MITA	-0.952
GHIXU	-0.943
WFRD	-0.939
BRIVU	-0.938
MSDA	-0.938
CCRC	-0.935
MMYT	-0.932
DSEY	-0.931

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Adial Pharmaceuticals Inc Korrelasjon - Valuta/Råvare

0.17
( neutral )

-0.24
( neutral )

0.00
( neutral )

-0.33
( neutral )

0.07
( neutral )

Adial Pharmaceuticals Inc Økonomi

Annual	2023
Omsetning:	$0
Bruttogevinst:	$-564.00 (0.00 %)
EPS:	$-5.44

FY	2023
Omsetning:	$0
Bruttogevinst:	$-564.00 (0.00 %)
EPS:	$-5.44

FY	2022
Omsetning:	$0
Bruttogevinst:	$-60 501.00 (0.00 %)
EPS:	$-317.81

FY	2021
Omsetning:	$0.00
Bruttogevinst:	$0.00 (0.00 %)
EPS:	$-1.971

Financial Reports:

No articles found.

Adial Pharmaceuticals Inc

Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment or prevention of addiction and related disorders. Its lead product is AD04, a selective serotonin-3 antagonist, which is in Phase III clinical trial for the treatment of alcohol use disorder. The company also focuses on developing drug candidates for non-opioid pain reduction and other diseases and disorders. Adial Pharmaceuticals, Inc. was founded in 2010 and is based in Charlottesville, Virginia.